# SCM Lifescience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scm-lifescience

- Industry: Biotechnology
- Headquarters: Incheon, South Korea
- Website: www.scmlifescience.com
- Total disclosed funding: $49M
- Latest round: Series C (Sep 1, 2018)
- Investors on record: 18

## About

Founded in 2014 and based in Incheon, South Korea, SCM Lifescience operates as a biotechnology company that develops stem cell isolation and stem cell production technology for patients with immunological conditions such as graft-versus-host disease(GVHD), atopic dermatitis, acute pancreatitis, diabetes, and asthma. In June 2020, SCM Lifescience raised KRW 30.6 billion in an IPO, selling 1.8 million shares at KRW 17,000 per share on the KOSDAQ.

## Funding rounds

- Series C, Sep 1, 2018, $35M — Yozma Group, Korea Investment & Securities, Meritz Securities, Shinhan Venture Investment, KB Investment, NH Investment & Securities, KDB Capital, Posco Investment, Samsung Securities, Sejong Venture Partners, Time Folio Asset Management, LSK Investment, QUAD Ventures, DAYLI Partners, DS Asset Management
- Series B, May 21, 2016, $8.4M — Korea Investment Partners, KDB Capital, DSC Investment, NHN Investment
- Series A, Mar 14, 2015, $6.2M — Korea Investment Partners, KDB Capital, DSC Investment

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A, Series B
- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series A, Series B, Series C
- DSC Investment (https://capitalatlas.ai/funds/dsc-investment) — Series A, Series B
- NHN Investment (https://capitalatlas.ai/funds/nhn-investment) — Series B
- Yozma Group (https://capitalatlas.ai/funds/yozma-group) — Series C
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series C
- Meritz Securities — Series C
- Shinhan Venture Investment (https://capitalatlas.ai/funds/shinhan-venture-investment) — Series C
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series C
- NH Investment & Securities (https://capitalatlas.ai/funds/nh-investment-securities) — Series C
- Posco Investment (https://capitalatlas.ai/funds/posco-investment) — Series C
- Samsung Securities — Series C
- Sejong Venture Partners — Series C
- Time Folio Asset Management — Series C
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series C
- QUAD Ventures (https://capitalatlas.ai/funds/quad-ventures) — Series C
- DAYLI Partners (https://capitalatlas.ai/funds/dayli-partners) — Series C
- DS Asset Management (https://capitalatlas.ai/funds/ds-asset-management) — Series C